{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T10:34:48Z","timestamp":1792924488342,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"DOI":"10.1038\/s41388-026-04025-y","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T17:41:09Z","timestamp":1792777269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer cell-specific FOXP3 licenses MMP19-dependent matrix remodeling and metastatic dissemination in pancreatic ductal adenocarcinoma"],"prefix":"10.1038","author":[{"given":"Junjin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chungen","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihai","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3205-8544","authenticated-orcid":false,"given":"Xiuchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuntao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruining","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9528-0580","authenticated-orcid":false,"given":"He","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"4025_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA: A Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA: A Cancer J Clin"},{"key":"4025_CR2","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729\u201354.","journal-title":"Cell"},{"key":"4025_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho WJ, Jaffee EM, Zheng L. The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities. Nat Rev Clin Oncol. 2020;17:527\u201340.","journal-title":"Nat Rev Clin Oncol"},{"key":"4025_CR4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3390\/cancers10090316","volume":"10","author":"M Weniger","year":"2018","unstructured":"Weniger M, Honselmann KC, Liss AS. The extracellular matrix and pancreatic cancer: a complex relationship. Cancers. 2018;10:316.","journal-title":"Cancers"},{"key":"4025_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.751311","volume":"11","author":"VM Perez","year":"2021","unstructured":"Perez VM, Kearney JF, Yeh JJ. The PDAC extracellular matrix: a review of the ECM protein composition, tumor cell interaction, and therapeutic strategies. Front Oncol. 2021;11:751311.","journal-title":"Front Oncol"},{"key":"4025_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2019.05.012","volume":"178","author":"M Ligorio","year":"2019","unstructured":"Ligorio M, Sil S, Malagon-Lopez J, Nieman LT, Misale S, Di Pilato M, et al. Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer. Cell. 2019;178:160\u2013175.e127.","journal-title":"Cell"},{"key":"4025_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","volume":"21","author":"PP Provenzano","year":"2012","unstructured":"Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21:418\u201329.","journal-title":"Cancer Cell"},{"key":"4025_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217898","volume":"630","author":"N Yao","year":"2025","unstructured":"Yao N, Fu Y, Wang T, Qin J, Cao Y, Shi M, et al. CEMIP2 sensitizes PDAC to chemotherapy through extracellular matrix remodeling by hyaluronan degradation. Cancer Lett. 2025;630:217898.","journal-title":"Cancer Lett"},{"key":"4025_CR9","doi-asserted-by":"publisher","first-page":"10495","DOI":"10.1074\/jbc.M110.195628","volume":"286","author":"MA Shields","year":"2011","unstructured":"Shields MA, Dangi-Garimella S, Krantz SB, Bentrem DJ, Munshi HG. Pancreatic cancer cells respond to type I collagen by inducing Snail expression to promote membrane type 1 matrix metalloproteinase-dependent collagen invasion. J Biol Chem. 2011;286:10495\u2013504.","journal-title":"J Biol Chem"},{"key":"4025_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217538","volume":"614","author":"C Quemerais","year":"2025","unstructured":"Quemerais C, Jean C, Brunel A, Decaup E, Labrousse G, Audureau H, et al. Unveiling FKBP7 as an early endoplasmic reticulum sentinel in pancreatic stellate cell activation, collagen remodeling and tumor progression. Cancer Lett. 2025;614:217538.","journal-title":"Cancer Lett"},{"key":"4025_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cr.2016.151","volume":"27","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Cell Res. 2017;27:109\u201318.","journal-title":"Cell Res"},{"key":"4025_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2020.07.022","volume":"490","author":"R Saleh","year":"2020","unstructured":"Saleh R, Elkord E. FoxP3+ T regulatory cells in cancer: prognostic biomarkers and therapeutic targets. Cancer Lett. 2020;490:174\u201385.","journal-title":"Cancer Lett"},{"key":"4025_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.982986","volume":"13","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Ke S, Chen J, Qin Z, Zhang W, Yuan Y, et al. FOXP3+ regulatory T cells and the immune escape in solid tumours. Front Immunol. 2022;13:982986.","journal-title":"Front Immunol"},{"key":"4025_CR14","doi-asserted-by":"publisher","first-page":"e003892","DOI":"10.1136\/jitc-2021-003892","volume":"10","author":"A Revenko","year":"2022","unstructured":"Revenko A, Carnevalli LS, Sinclair C, Johnson B, Peter A, Taylor M, et al. Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer. J Immunother Cancer. 2022;10:e003892.","journal-title":"J Immunother Cancer"},{"key":"4025_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08911-4","volume":"21","author":"S Kiryu","year":"2021","unstructured":"Kiryu S, Ito Z, Suka M, Bito T, Kan S, Uchiyama K, et al. Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma. BMC Cancer. 2021;21:1197.","journal-title":"BMC Cancer"},{"key":"4025_CR16","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1097\/JS9.0000000000002733","volume":"111","author":"N Pu","year":"2025","unstructured":"Pu N, Chen Q, Han J, Xu Z, Jiang Z, He T, et al. Intratumoral IL-33+CD4+FoxP3+ regulatory T cell infiltration determines poor clinical outcomes and intensive immunoevasive contexture in patients with pancreatic cancer after surgical resection: a cohort study. Int J Surg. 2025;111:6245\u201359.","journal-title":"Int J Surg"},{"key":"4025_CR17","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.cell.2007.04.034","volume":"129","author":"T Zuo","year":"2007","unstructured":"Zuo T, Wang L, Morrison C, Chang X, Zhang H, Li W, et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2\/ErbB2 oncogene. Cell. 2007;129:1275\u201386.","journal-title":"Cell"},{"key":"4025_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2009.06.001","volume":"287","author":"HY Zhang","year":"2010","unstructured":"Zhang HY, Sun H. Up-regulation of Foxp3 inhibits cell proliferation, migration, and invasion in epithelial ovarian cancer. Cancer Lett. 2010;287:91\u201397.","journal-title":"Cancer Lett"},{"key":"4025_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/path.4381","volume":"234","author":"S Douglass","year":"2014","unstructured":"Douglass S, Meeson AP, Overbeck-Zubrzycka D, Brain JG, Bennett MR, Lamb CA, et al. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12. J Pathol. 2014;234:74\u201385.","journal-title":"J Pathol"},{"key":"4025_CR20","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.3390\/molecules27196706","volume":"27","author":"B Ma","year":"2022","unstructured":"Ma B, Miao W, Xiao J, Chen X, Xu J, Li Y. The role of FOXP3 on tumor metastasis and its interaction with traditional Chinese medicine. Molecules. 2022;27:6706.","journal-title":"Molecules"},{"key":"4025_CR21","doi-asserted-by":"publisher","first-page":"8344","DOI":"10.1158\/0008-5472.CAN-06-3304","volume":"67","author":"S Hinz","year":"2007","unstructured":"Hinz S, Pagerols-Raluy L, Oberg HH, Ammerpohl O, Grussel S, Sipos B, et al. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res. 2007;67:8344\u201350.","journal-title":"Cancer Res"},{"key":"4025_CR22","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1038\/onc.2016.458","volume":"36","author":"X Wang","year":"2017","unstructured":"Wang X, Lang M, Zhao T, Feng X, Zheng C, Huang C, et al. Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+ Treg cells in pancreatic ductal adenocarcinoma. Oncogene. 2017;36:3048\u201358.","journal-title":"Oncogene"},{"key":"4025_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-020-0144-8","volume":"5","author":"X Wang","year":"2020","unstructured":"Wang X, Li X, Wei X, Jiang H, Lan C, Yang S, et al. PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC. Signal Transduct Target Ther. 2020;5:38.","journal-title":"Signal Transduct Target Ther"},{"key":"4025_CR24","doi-asserted-by":"publisher","first-page":"C294","DOI":"10.1152\/ajpcell.00461.2023","volume":"326","author":"R Gong","year":"2024","unstructured":"Gong R, Chen X, Sun X, Zhang Y, Wang J, Yu Q, et al. Identification of FOXP3+ epithelial cells contributing to pancreatic proliferation and angiogenesis. Am J Physiol Cell Physiol. 2024;326:C294\u2013C303.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4025_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216838","volume":"590","author":"R Gong","year":"2024","unstructured":"Gong R, Wang J, Xing Y, Wang J, Chen X, Lei K, et al. Expression landscape of cancer-FOXP3 and its prognostic value in pancreatic adenocarcinoma. Cancer Lett. 2024;590:216838.","journal-title":"Cancer Lett"},{"key":"4025_CR26","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1083\/jcb.149.6.1309","volume":"149","author":"K Hotary","year":"2000","unstructured":"Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol. 2000;149:1309\u201323.","journal-title":"J Cell Biol"},{"key":"4025_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/biology9040080","volume":"9","author":"EJ Slapak","year":"2020","unstructured":"Slapak EJ, Duitman J, Tekin C, Bijlsma MF, Spek CA. Matrix metalloproteases in pancreatic ductal adenocarcinoma: key drivers of disease progression? Biology. 2020;9:80.","journal-title":"Biology"},{"key":"4025_CR28","doi-asserted-by":"publisher","first-page":"e0248111","DOI":"10.1371\/journal.pone.0248111","volume":"16","author":"H Cao","year":"2021","unstructured":"Cao H, Qiang L, Chen J, Johnson KM, McNiven MA, Razidlo GL. Synergistic metalloproteinase-based remodeling of matrix by pancreatic tumor and stromal cells. PLoS One. 2021;16:e0248111.","journal-title":"PLoS One"},{"key":"4025_CR29","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/MPA.0000000000000569","volume":"45","author":"LL Zhai","year":"2016","unstructured":"Zhai LL, Wu Y, Cai CY, Huang Q, Tang ZG. High-level expression and prognostic significance of matrix metalloprotease-19 and matrix metalloprotease-20 in human pancreatic ductal adenocarcinoma. Pancreas. 2016;45:1067\u201372.","journal-title":"Pancreas"},{"key":"4025_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57517-6","volume":"10","author":"GJ Lim","year":"2020","unstructured":"Lim GJ, Kang SJ, Lee JY. Novel invasion indices quantify the feed-forward facilitation of tumor invasion by macrophages. Sci Rep. 2020;10:718.","journal-title":"Sci Rep"},{"key":"4025_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201700140","volume":"12","author":"C Moriconi","year":"2017","unstructured":"Moriconi C, Palmieri V, Di Santo R, Tornillo G, Papi M, Pilkington G, et al. INSIDIA: a FIJI macro delivering high-throughput and high-content spheroid invasion analysis. Biotechnol J. 2017;12:1700140.","journal-title":"Biotechnol J"},{"key":"4025_CR32","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1158\/1078-0432.CCR-24-1818","volume":"31","author":"LL Siu","year":"2025","unstructured":"Siu LL, Postel-Vinay S, Villanueva-V\u00e1zquez R, de Velasco G, Castanon \u00c1lvarez E, Kyriakopoulos CE, et al. AZD8701, an antisense oligonucleotide targeting FOXP3 mRNA, as monotherapy and in combination with durvalumab: a phase I trial in patients with advanced solid tumors. Clin Cancer Res. 2025;31:1449\u201362.","journal-title":"Clin Cancer Res"},{"key":"4025_CR33","doi-asserted-by":"publisher","unstructured":"Gong R, Wang J, Ren M, Zhang W, Ping S, Jing Y, et al. Epithelial FOXP3 Orchestrates O-Glycosylated IL6 Secretion to Drive Pancreatic Fibrocarcinogenesis. Gastroenterology 2026. https:\/\/doi.org\/10.1053\/j.gastro.2026.06.007.","DOI":"10.1053\/j.gastro.2026.06.007"},{"key":"4025_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217995","volume":"633","author":"D Zhou","year":"2025","unstructured":"Zhou D, Zhang J, Deng X, Lu X, Liu X, Yu J, et al. SUSD2 hypersialylation promotes early lung adenocarcinoma progression by driving ECM remodeling and pro-tumorigenic fibroblast activation. Cancer Lett. 2025;633:217995.","journal-title":"Cancer Lett"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-04025-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-04025-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-04025-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T10:01:54Z","timestamp":1792922514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-04025-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":34,"alternative-id":["4025"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-04025-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"7 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study involving human tissue samples was reviewed and approved by the Ethics Committee of Qingdao University (approval no. QYFYWZLL50262). Written informed consent was obtained from all participants prior to the use of their tissue samples. All animal procedures were approved by the Institutional Animal Care and Use Committee of Qingdao University (approval no. AHQU-MAL20251106JYY). All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}